| Event chart VERTEX PHARMACEUTICALS |
|
|
|
| Upcoming events on VERTEX PHARMACEUTICALS |
|
| 07/27/22 | | Interim 2022 Earnings Release (Projected) |
| 11/02/22 | | Q3 2022 Earnings Release (Projected) |
| 02/01/23 | | FY 2022 Earnings Release (Projected) |
| 04/27/23 | | Q1 2023 Earnings Release (Projected) |
|
| Past events on VERTEX PHARMACEUTICALS |
|
| 05/18/22 | | Annual General Meeting |
| 05/05/22 | 04:30pm | | Q1 2022 Earnings Call |
| 05/05/22 | 04:01pm | | Q1 2022 Earnings Release |
| 03/08/22 | 02:50pm | | Cowen & Co. Health Care Conference |
| 01/26/22 | 04:30pm | | FY 2021 Earnings Call |
| 01/26/22 | 04:01pm | | FY 2021 Earnings Release |
| 01/10/22 | 09:00am | | JP Morgan Healthcare Conference |
| 12/01/21 | 08:30am | | VX-147 Phase 2 Clinical Results |
| 11/02/21 | 03:30pm | | Q3 2021 Earnings Call |
| 11/02/21 | | North American Cystic Fibrosis Conference - Poster No - 285 |
|
| Past dividends on VERTEX PHARMACEUTICALS |
|
- No events available -
|
|
|
| Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales
M $ |
Released
Forecast
Spread | 2 489
2 431
2,4% | 3 048
2 992
1,9% | 4 163
3 759
11% | 6 206
6 159
0,76% | 7 574
7 502
0,97% |
8 585
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 185
119
56% | 1 184
1 123
5,4% | 1 893
1 770
6,9% | 3 601
3 649
-1,3% | 4 470
4 490
-0,46% |
4 995
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 564
538
4,9% | 1 112
1 052
5,7% | 1 786
1 609
11% | 3 491
3 471
0,58% | 4 344
4 345
-0,02% |
4 739
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -15,7
-70,5
78% | 600
771
-22% | 1 395
964
45% | 3 117
2 891
7,8% | 2 730
2 761
-1,1% |
4 065
|
Net income
M $ |
Released
Forecast
Spread | 263
237
11% | 2 097
740
183% | 1 177
796
48% | 2 712
2 608
4,0% | 2 342
2 295
2,1% |
3 253
|
EPS
$ |
Released
Forecast
Spread | 1,04
0,90
15% | 8,09
2,84
185% | 4,51
3,08
46% | 10,3
9,87
4,2% | 9,01
8,80
2,4% |
12,6
| | Announcement Date | 01/31/2018 | 02/05/2019 | 01/30/2020 | 02/01/2021 | 01/26/2022 | - |
|
|
|
| Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
Sales
M $ |
Released
Forecast
Spread | 1 515
1 287
18% | 1 524
1 393
9,4% | 1 538
1 480
3,9% | 1 628
1 585
2,7% | 1 724
1 657
4,1% | 1 793
1 726
3,9% | 1 984
1 864
6,4% | 2 073
2 007
3,3% | 2 098
2 074
1,1% |
2 132
|
2 166
|
2 196
|
2 227
|
2 279
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 747
759
-1,6% | 901
875
2,9% | 881
890
-1,1% | 916
1 001
-8,5% |
|
|
|
|
|
|
|
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 877
628
40% | 874
725
21% | 854
797
7,2% | 887
872
1,7% | 1 003
921
8,8% | 1 029
949
8,5% | 1 188
1 041
14% | 1 124
1 126
-0,15% | 1 167
1 188
-1,8% |
1 191
|
1 203
|
1 180
|
1 249
|
1 266
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 658
531
24% | 825
569
45% | 746
658
13% | 889
704
26% | 821
759
8,2% | -44,3
188
-124% | 1 083
844
28% | 871
908
-4,1% | 955
995
-4,0% |
1 024
|
1 028
|
1 070
|
1 067
|
1 101
|
Net income
M $ |
Released
Forecast
Spread | 603
408
48% | 837
433
93% | 667
523
28% | 604
577
4,8% | 653
615
6,1% | 66,9
110
-39% | 852
674
26% | 770
720
7,0% | 762
801
-4,8% |
828
|
830
|
810
|
825
|
848
|
EPS
$ |
Released
Forecast
Spread | 2,29
1,60
43% | 3,18
1,66
91% | 2,53
1,98
28% | 2,30
2,13
8,2% | 2,49
2,29
8,7% | 0,26
0,69
-62% | 3,28
2,51
31% | 3,00
2,76
8,6% | 2,96
3,14
-5,6% |
3,13
|
3,17
|
3,26
|
3,20
|
3,29
| | Announcement Date | 04/29/2020 | 07/30/2020 | 10/29/2020 | 02/01/2021 | 04/29/2021 | 07/29/2021 | 11/02/2021 | 01/26/2022 | 05/05/2022 | - | - | - | - | - | |
|
|
| Upcoming sector events for VERTEX PHARMACEUTICALS |
|
| |
|
| Past sector events for VERTEX PHARMACEUTICALS |
|
| |
|
|
|
|
PUMP / DUMP #13 : This week's gainers and losers |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year